# A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC

> **NCT04794140** · NA · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 60 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **PROCEDURE:** different number of passes

## Key facts

- **NCT ID:** NCT04794140
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-15
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04794140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04794140, "A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04794140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*